Identification of the receptor-binding sites in the carboxyl-terminal half of the heavy chain of botulinum neurotoxin types C and D

Microbial Pathogenesis

Volumn 44, Issue 6, 2008, Pages 484-493

  Tsukamoto, Kentaro ^a   Kozai, Yuiko ^b   Ihara, Hideshi ^b   Kohda, Tomoko ^b   Mukamoto, Masafumi ^b   Tsuji, Takao ^a   Kozaki, Shunji ^b  

^a FUJITA HEALTH UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Osaka Prefecture University   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN; BOTULINUM TOXIN C; BOTULINUM TOXIN D; GANGLIOSIDE GD 1B; GANGLIOSIDE GT 1B;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; BINDING SITE; BOTULISM; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; HEAVY CHAIN; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; RAT; RECEPTOR BINDING; SITE DIRECTED MUTAGENESIS;

AMINO ACID SEQUENCE; ANIMALS; BINDING SITES; BOTULINUM TOXINS; CHIMERIN PROTEINS; CLOSTRIDIUM BOTULINUM; MOLECULAR SEQUENCE DATA; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; RATS; SEQUENCE ALIGNMENT; SNARE PROTEINS; SYNAPTOSOMES;

EID: 43049163811     PISSN: 08824010     EISSN: 10961208     Source Type: Journal    
DOI: 10.1016/j.micpath.2007.12.003     Document Type: Article

References (40)

1. Simpson L.L. Molecular pharmacology of botulinum toxin and tetanus toxin. Annu Rev Pharmacol Toxicol 26 (1986) 427-453
2. Collins M.D., and East A.K. Phylogeny and taxonomy of the food-borne pathogen Clostridium botulinum and its neurotoxins. J Appl Microbiol 84 (1998) 5-17
3. Takeda M., Tsukamoto K., Kohda T., Matsui M., Mukamoto M., and Kozaki S. Characterization of the neurotoxin produced by isolates associated with avian botulism. Avian Dis 49 (2005) 376-381
4. Moriishi K., Koura M., Abe N., Fujii N., Fujinaga Y., Inoue K., et al. Mosaic structures of neurotoxins produced from Clostridium botulinum types C and D organisms. Biochim Biophys Acta 1307 (1996) 123-126
5. Moriishi K., Koura M., Fujii N., Fujinaga Y., Inoue K., Syuto B., et al. Molecular cloning of the gene encoding the mosaic neurotoxin, composed of parts of botulinum neurotoxin types C1 and D, and PCR detection of this gene from Clostridium botulinum type C organisms. Appl Environ Microbiol 62 (1996) 662-667
6. Blasi J., Chapman E.R., Yamasaki S., Binz T., Niemann H., and Jahn R. Botulinum neurotoxin C1 blocks neurotransmitter release by means of cleaving HPC-1/syntaxin. EMBO J 12 (1993) 4821-4828
7. Montecucco C., and Schiavo G. Mechanism of action of tetanus and botulinum neurotoxins. Mol Microbiol 13 (1994) 1-8
8. Niemann H., Blasi J., and Jahn R. Clostridial neurotoxins: new tools for dissecting exocytosis. Trends Cell Biol 4 (1994) 179-185
9. Yamasaki S., Baumeister A., Binz T., Blasi J., Link E., Cornille F., et al. Cleavage of members of the synaptobrevin/VAMP family by types D and F botulinal neurotoxins and tetanus toxin. J Biol Chem 269 (1994) 12764-12772
10. Breidenbach M.A., and Brunger A.T. New insights into clostridial neurotoxin-SNARE interactions. Trends Mol Med 11 (2005) 377-381
11. Fu Z., Chen S., Baldwin M.R., Boldt G.E., Crawford A., Janda K.D., et al. Light chain of botulinum neurotoxin serotype A: structural resolution of a catalytic intermediate. Biochemistry 45 (2006) 8903-8911
12. Schiavo G., Matteoli M., and Montecucco C. Neurotoxins affecting neuroexocytosis. Physiol Rev 80 (2000) 717-766
13. Blaustein R.O., Germann W.J., Finkelstein A., and DasGupta B.R. The N-terminal half of the heavy chain of botulinum type A neurotoxin forms channels in planar phospholipid bilayers. FEBS Lett 226 (1987) 115-120
14. Lebeda F.J., and Olson M.A. Structural predictions of the channel-forming region of botulinum neurotoxin heavy chain. Toxicon 33 (1995) 559-567
15. Kamata Y., Kozaki S., Sakaguchi G., Iwamori M., and Nagai Y. Evidence for direct binding of Clostridium botulinum type E derivative toxin and its fragments to gangliosides and free fatty acids. Biochem Biophys Res Commun 140 (1986) 1015-1019
16. Takamizawa K., Iwamori M., Kozaki S., Sakaguchi G., Tanaka R., Takayama H., et al. TLC immunostaining characterization of Clostridium botulinum type A neurotoxin binding to gangliosides and free fatty acids. FEBS Lett 201 (1986) 229-232
17. Van Heyningen W.E., and Miller P.A. The fixation of tetanus toxin by ganglioside. J Gen Microbiol 24 (1961) 107-119
18. Yowler B.C., Kensinger R.D., and Schengrund C.L. Botulinum neurotoxin A activity is dependent upon the presence of specific gangliosides in neuroblastoma cells expressing synaptotagmin I. J Biol Chem 277 (2002) 32815-32819
19. C fragment of tetanus toxin with carbohydrate subunit complexes provide insight into ganglioside binding. J Biol Chem 275 (2000) 8889-8894
20. C fragment complexed with a synthetic GT1b analogue suggests cross-linking between ganglioside receptors and the toxin. J Biol Chem 276 (2001) 32274-32281
21. Kohda T., Ihara H., Seto Y., Tsutsuki H., Mukamoto M., and Kozaki S. Differential contribution of the residues in C-terminal half of the heavy chain of botulinum neurotoxin type B to its binding to the ganglioside GT1b and the synaptotagmin 2/GT1b complex. Microb Pathog 42 (2007) 72-79
22. Lacy D.B., Tepp W., Cohen A.C., DasGupta B.R., and Stevens R.C. Crystal structure of botulinum neurotoxin type A and implications for toxicity. Nat Struct Biol 5 (1998) 898-902
23. Swaminathan S., and Eswaramoorthy S. Structural analysis of the catalytic and binding sites of Clostridium botulinum neurotoxin B. Nat Struct Biol 7 (2000) 693-699
24. Dong M., Richards D.A., Goodnough M.C., Tepp W.H., Johnson E.A., and Chapman E.R. Synaptotagmins I and II mediate entry of botulinum neurotoxin B into cells. J Cell Biol 162 (2003) 1293-1303
25. Nishiki T., Kamata Y., Nemoto Y., Omori A., Ito T., Takahashi M., et al. Identification of protein receptor for Clostridium botulinum type B neurotoxin in rat brain synaptosomes. J Biol Chem 269 (1994) 10498-10503
26. Nishiki T., Tokuyama Y., Kamata Y., Nemoto Y., Yoshida A., Sato K., et al. The high-affinity binding of Clostridium botulinum type B neurotoxin to synaptotagmin II associated with gangliosides GT1b/GD1a. FEBS Lett 378 (1996) 253-257
27. Dong M., Yeh F., Tepp W.H., Dean C., Johnson E.A., Janz R., et al. SV2 is the protein receptor for botulinum neurotoxin A. Science 312 (2006) 592-596
28. Mahrhold S., Rummel A., Bigalke H., Davletov B., and Binz T. The synaptic vesicle protein 2C mediates the uptake of botulinum neurotoxin A into phrenic nerves. FEBS Lett 580 (2006) 2011-2014
29. Tsukamoto K., Kohda T., Mukamoto M., Takeuchi K., Ihara H., Saito M., et al. Binding of Clostridium botulinum type C and D neurotoxins to ganglioside and phospholipid. Novel insights into the receptor for clostridial neurotoxins. J Biol Chem 280 (2005) 35164-35171
30. Horton R.M., Cai Z.L., Ho S.N., and Pease L.R. Gene splicing by overlap extension: tailor-made genes using the polymerase chain reaction. Biotechniques 8 (1990) 528-535
31. Kozaki S. Interaction of botulinum type A, B and E derivative toxins with synaptosomes of rat brain. Naunyn-Schmiedeberg's Arch Pharmacol 308 (1979) 67-70
32. Whittaker V.P. The isolation and characterization of acetylcholine-containing particles from brain. Biochem J 72 (1959) 694-706
33. Ihara H., Kohda T., Morimoto F., Tsukamoto K., Karasawa T., Nakamura S., et al. Sequence of the gene for Clostridium botulinum type B neurotoxin associated with infant botulism, expression of the C-terminal half of heavy chain and its binding activity. Biochim Biophys Acta 1625 (2003) 19-26
34. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227 (1970) 680-685
35. Lowry O.H., Rosebrough N.J., Farr A.L., and Randall R.J. Protein measurement with the Folin phenol reagent. J Biol Chem 193 (1951) 265-275
36. CC-domain of tetanus neurotoxin are required for toxicity. J Mol Biol 326 (2003) 835-847
37. Machaidze G., and Seelig J. Specific binding of cinnamycin (Ro 09-0198) to phosphatidylethanolamine. Comparison between micellar and membrane environments. Biochemistry 42 (2003) 12570-12576
38. Machaidze G., Ziegler A., and Seelig J. Specific binding of Ro 09-0198 (cinnamycin) to phosphatidylethanolamine: a thermodynamic analysis. Biochemistry 41 (2002) 1965-1971
39. CC-domain of botulinum neurotoxins A and B exhibits a singular ganglioside binding site displaying serotype specific carbohydrate interaction. Mol Microbiol 51 (2004) 631-643
40. Halpern J.L., and Loftus A. Characterization of the receptor-binding domain of tetanus toxin. J Biol Chem 268 (1993) 11188-11192